Brain metabolic alterations in patients with long-term calcineurin inhibitor therapy after liver transplantation.


Journal

Alimentary pharmacology & therapeutics
ISSN: 1365-2036
Titre abrégé: Aliment Pharmacol Ther
Pays: England
ID NLM: 8707234

Informations de publication

Date de publication:
06 2019
Historique:
received: 29 11 2018
revised: 24 12 2018
accepted: 20 03 2019
pubmed: 23 4 2019
medline: 15 4 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

Calcineurin inhibitor (CNI) neurotoxicity after liver transplantation might be due to impairment of the cerebral metabolism. To investigate CNI-related alterations of brain metabolite distributions and associations between cognitive function and brain metabolism in patients with long-term CNI treatment after liver transplantation. Eighty-two patients (19 CNI free, 34 CNI low-dose and 29 standard-dose CNI immunosuppression) 10 years after liver transplantation and 32 adjusted healthy controls underwent nonlocalised brain phosphorus magnetic resonance spectroscopy (MRS) and single voxel proton MRS in the parietal white matter to estimate brain metabolite contents. The MRS results were correlated with psychometric data assessing cognitive function. Phosphorus metabolite concentrations with the exception of phosphocreatine (PCr) were reduced in patients compared to controls. Particularly, patients with low-dose CNI therapy showed a significant decrease in adenosine triphosphate (0.209 ± 0.012 vs 0.222 ± 0.010; P < 0.001) and a significant increase in PCr (0.344 ± 0.026 vs 0.321 ± 0.017; P < 0.001) compared to controls. Myo-Inositol in the CNI free group (2.719 ± 0.549 institutional unit [iu]) was significantly lower compared to controls (3.181 ± 0.425 iu; P = 0.02), patients on low-dose (3.130 ± 0.513 iu; P < 0.05) and standard-dose CNI therapy (3.207 ± 0.632 iu; P < 0.02). Glutamate and glutamine levels correlated negatively with cognitive function (Repeatable Battery for the Assessment of Neuropsychological Status Total Scale: R = -0.362, P = 0.029). Long-term CNI therapy after liver transplantation might be associated with alterations of brain metabolites.

Sections du résumé

BACKGROUND
Calcineurin inhibitor (CNI) neurotoxicity after liver transplantation might be due to impairment of the cerebral metabolism.
AIMS
To investigate CNI-related alterations of brain metabolite distributions and associations between cognitive function and brain metabolism in patients with long-term CNI treatment after liver transplantation.
METHODS
Eighty-two patients (19 CNI free, 34 CNI low-dose and 29 standard-dose CNI immunosuppression) 10 years after liver transplantation and 32 adjusted healthy controls underwent nonlocalised brain phosphorus magnetic resonance spectroscopy (MRS) and single voxel proton MRS in the parietal white matter to estimate brain metabolite contents. The MRS results were correlated with psychometric data assessing cognitive function.
RESULTS
Phosphorus metabolite concentrations with the exception of phosphocreatine (PCr) were reduced in patients compared to controls. Particularly, patients with low-dose CNI therapy showed a significant decrease in adenosine triphosphate (0.209 ± 0.012 vs 0.222 ± 0.010; P < 0.001) and a significant increase in PCr (0.344 ± 0.026 vs 0.321 ± 0.017; P < 0.001) compared to controls. Myo-Inositol in the CNI free group (2.719 ± 0.549 institutional unit [iu]) was significantly lower compared to controls (3.181 ± 0.425 iu; P = 0.02), patients on low-dose (3.130 ± 0.513 iu; P < 0.05) and standard-dose CNI therapy (3.207 ± 0.632 iu; P < 0.02). Glutamate and glutamine levels correlated negatively with cognitive function (Repeatable Battery for the Assessment of Neuropsychological Status Total Scale: R = -0.362, P = 0.029).
CONCLUSION
Long-term CNI therapy after liver transplantation might be associated with alterations of brain metabolites.

Identifiants

pubmed: 31006881
doi: 10.1111/apt.15256
doi:

Substances chimiques

Calcineurin Inhibitors 0
Glutamine 0RH81L854J
Glutamic Acid 3KX376GY7L
Adenosine Triphosphate 8L70Q75FXE

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1431-1441

Subventions

Organisme : German Federal Ministry of Education and Research
ID : 01EO1302
Pays : International
Organisme : German Research Foundation
Pays : International

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Birte Schmitz (B)

Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.

Henning Pflugrad (H)

Department of Neurology, Hannover Medical School, Hannover, Germany.
Integrated Research and Treatment Centre Transplantation, Hannover Medical School, Hannover, Germany.

Anita B Tryc (AB)

Department of Neurology, Hannover Medical School, Hannover, Germany.
Integrated Research and Treatment Centre Transplantation, Hannover Medical School, Hannover, Germany.

Heinrich Lanfermann (H)

Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.

Elmar Jäckel (E)

Integrated Research and Treatment Centre Transplantation, Hannover Medical School, Hannover, Germany.
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.

Harald Schrem (H)

Core Facility Quality Management and Health Technology Assessment in Transplantation, Hannover Medical School, Hannover, Germany.
Clinic for Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.

Jan Beneke (J)

Core Facility Quality Management and Health Technology Assessment in Transplantation, Hannover Medical School, Hannover, Germany.

Hannelore Barg-Hock (H)

Clinic for Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.

Jürgen Klempnauer (J)

Integrated Research and Treatment Centre Transplantation, Hannover Medical School, Hannover, Germany.
Clinic for Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.

Karin Weissenborn (K)

Department of Neurology, Hannover Medical School, Hannover, Germany.
Integrated Research and Treatment Centre Transplantation, Hannover Medical School, Hannover, Germany.

Xiao-Qi Ding (XQ)

Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH